Benucci, M.; Cioffi, E.; Li Gobbi, F.; Cassarà , E.A.M.; Terenzi, R.; Russo, E.; Grossi, V.; Lari, B.; Infantino, M.; Manfredi, M.
Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation. Antibodies 2026, 15, 24.
https://doi.org/10.3390/antib15020024
AMA Style
Benucci M, Cioffi E, Li Gobbi F, Cassarà EAM, Terenzi R, Russo E, Grossi V, Lari B, Infantino M, Manfredi M.
Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation. Antibodies. 2026; 15(2):24.
https://doi.org/10.3390/antib15020024
Chicago/Turabian Style
Benucci, Maurizio, Elisa Cioffi, Francesca Li Gobbi, Emanuele Antonio Maria Cassarà , Riccardo Terenzi, Edda Russo, Valentina Grossi, Barbara Lari, Maria Infantino, and Mariangela Manfredi.
2026. "Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation" Antibodies 15, no. 2: 24.
https://doi.org/10.3390/antib15020024
APA Style
Benucci, M., Cioffi, E., Li Gobbi, F., Cassarà , E. A. M., Terenzi, R., Russo, E., Grossi, V., Lari, B., Infantino, M., & Manfredi, M.
(2026). Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation. Antibodies, 15(2), 24.
https://doi.org/10.3390/antib15020024
